KLF5 promotes apoptosis induced by phorbol ester as an effector of the autocrine factor TNFα in LNCaP prostate cancer cells

Shi,Qi; Jia,Jing; Hui,Ke; Gao,Yang; Xu,Shan; Guan,Bing; Tang,Xiaoshuang; Wang,Xinyang; He,Dalin; Guo,Peng

doi:10.3892/ol.2017.6293

KLF5 promotes apoptosis induced by phorbol ester as an effector of the autocrine factor TNFα in LNCaP prostate cancer cells

Authors:
- Qi Shi
- Jing Jia
- Ke Hui
- Yang Gao
- Shan Xu
- Bing Guan
- Xiaoshuang Tang
- Xinyang Wang
- Dalin He
- Peng Guo
View Affiliations

Affiliations: Department of Urology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China
Published online on: June 1, 2017 https://doi.org/10.3892/ol.2017.6293
Pages: 1847-1854

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Krüppel‑like factor 5 (KLF5) is frequently deleted and inactivated in prostate cancer, and exerts tumor‑suppressing function in prostate cancer cells. However, the function of KLF5 in the apoptosis of prostate cancer cells remains unclear. In the present study, the effect of KLF5 on phorbol 12‑myristate 13‑acetate (PMA)‑induced apoptosis was investigated in prostate cancer LNCaP cells. It was demonstrated that PMA induced the expression of KLF5 at the mRNA and protein level. To identify whether KLF5 regulates the activity of the downstream pathway, stable KLF5 knockdown or overexpression cell lines were constructed with lentivirus harboring shRNA targeting KLF5 or full‑length KLF5 in LNCaP cells. Knockdown of KLF5 significantly decreased PMA‑induced apoptosis, while cell apoptosis was significantly increased following KLF5 overexpression compared with the corresponding control groups. Consistently, expression of cleaved poly(ADP‑ribose) polymerase and caspase‑3 induced by PMA was decreased following KLF5 knockdown and increased following KLF5 overexpression. Using the control medium from cells treated with PMA, it was demonstrated that KLF5 is required for the control medium to induce apoptosis. c‑Jun N‑terminal kinase (JNK) activity is essential for the apoptosis induced by PMA. It was revealed that knockdown of KLF5 decreased, while overexpression of KLF5 increased the phosphorylation of JNK induced by PMA and control medium treatment. Furthermore, inhibition of tumor necrosis factor α (TNFα) decreased KLF5 expression and significantly decreased cell apoptosis induced by PMA, and control medium. This data indicates that KLF5 is essential for the apoptosis induced by PMA in LNCaP prostate cancer cells. Furthermore, KLF5 is essential for activity of the autocrine factor TNFα, which is secreted by cells treated with PMA and mediates the function of PMA‑induced apoptosis through regulating the activity of JNK signaling pathway. These results provide novel insights into the complexity of the signaling pathways regulating apoptosis in prostate cancer cells, which could aid in the development of novel treatments for patients with prostate cancer.

View Figures

View References

1	Siegel RL, Miller KD and Jemal A: Cancer statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
2	Mukherji D, Omlin A, Pezaro C, Shamseddine A and de Bono J: Metastatic castration-resistant prostate cancer (CRPC): Preclinical and clinical evidence for the sequential use of novel therapeutics. Cancer Metastasis Rev. 33:555–566. 2014.PubMed/NCBI
3	Barry OP and Kazanietz MG: Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des. 7:1725–1744. 2001. View Article : Google Scholar : PubMed/NCBI
4	Garcia-Bermejo ML, Leskow FC, Fujii T, Wang Q, Blumberg PM, Ohba M, Kuroki T, Han KC, Lee J, Marquez VE and Kazanietz MG: Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha. J Biol Chem. 277:645–655. 2002. View Article : Google Scholar : PubMed/NCBI
5	Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T and Kazanietz MG: Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem. 278:33753–33762. 2003. View Article : Google Scholar : PubMed/NCBI
6	Xiao L, Eto M and Kazanietz MG: ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK. J Biol Chem. 284:29365–29375. 2009. View Article : Google Scholar : PubMed/NCBI
7	Gonzalez-Guerrico AM and Kazanietz MG: Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: A key role for protein kinase C delta. J Biol Chem. 280:38982–38991. 2005. View Article : Google Scholar : PubMed/NCBI
8	Xiao L, Gonzalez-Guerrico A and Kazanietz MG: PKC-mediated secretion of death factors in LNCaP prostate cancer cells is regulated by androgens. Mol Carcinog. 48:187–195. 2009. View Article : Google Scholar : PubMed/NCBI
9	Guo P, Dong XY, Zhang X, Zhao KW, Sun X, Li Q and Dong JT: Pro-proliferative factor KLF5 becomes anti-proliferative in epithelial homeostasis upon signaling-mediated modification. J Biol Chem. 284:6071–6078. 2009. View Article : Google Scholar : PubMed/NCBI
10	Gao Y, Wu K, Chen Y, Zhou J, Du C, Shi Q, Xu S, Jia J, Tang X, Li F, et al: Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription. Oncotarget. 6:43791–43805. 2015.PubMed/NCBI
11	Gao Y, Shi Q, Xu S, Du C, Liang L, Wu K, Wang K, Wang X, Chang LS, He D and Guo P: Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells. Int J Mol Sci. 15:15173–15187. 2014. View Article : Google Scholar : PubMed/NCBI
12	Tong D, Czerwenka K, Heinze G, Ryffel M, Schuster E, Witt A, Leodolter S and Zeillinger R: Expression of KLF5 is a prognostic factor for disease-free survival and overall survival in patients with breast cancer. Clin Cancer Res. 12:2442–2448. 2006. View Article : Google Scholar : PubMed/NCBI
13	Tarapore RS, Yang Y and Katz JP: Restoring KLF5 in esophageal squamous cell cancer cells activates the JNK pathway leading to apoptosis and reduced cell survival. Neoplasia. 15:472–480. 2013. View Article : Google Scholar : PubMed/NCBI
14	Chen C, Bhalala HV, Vessella RL and Dong JT: KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Prostate. 55:81–88. 2003. View Article : Google Scholar : PubMed/NCBI
15	Chen C, Sun X, Ran Q, Wilkinson KD, Murphy TJ, Simons JW and Dong JT: Ubiquitin-proteasome degradation of KLF5 transcription factor in cancer and untransformed epithelial cells. Oncogene. 24:3319–3327. 2005. View Article : Google Scholar : PubMed/NCBI
16	Aggarwal BB: Signalling pathways of the TNF superfamily: A double-edged sword. Nat Rev Immunol. 3:745–756. 2003. View Article : Google Scholar : PubMed/NCBI
17	Chopra DP, Menard RE, Januszewski J and Mattingly RR: TNF-alpha-mediated apoptosis in normal human prostate epithelial cells and tumor cell lines. Cancer Lett. 203:145–154. 2004. View Article : Google Scholar : PubMed/NCBI
18	Shi Q, Gao Y, Xu S, Du C, Li F, Tang XS, Jia J, Wang X, Chang L, He D and Guo P: Kruppel-like factor 5 promotes apoptosis triggered by tumor necrosis factor α in LNCaP prostate cancer cells via up-regulation of mitogen-activated protein kinase kinase 7. Urol Oncol. 34:58.e11–e18. 2016. View Article : Google Scholar
19	Bafford R, Sui XX, Wang G and Conte M: Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: Potential relevance to vein graft hyperplasia. Surgery. 140:289–296. 2006. View Article : Google Scholar : PubMed/NCBI
20	Chen C, Bhalala HV, Qiao H and Dong JT: A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene. 21:6567–6572. 2002. View Article : Google Scholar : PubMed/NCBI
21	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
22	Lorenzo PI and Saatcioglu F: Inhibition of apoptosis in prostate cancer cells by androgens is mediated through downregulation of c-Jun N-terminal kinase activation. Neoplasia. 10:418–428. 2008. View Article : Google Scholar : PubMed/NCBI
23	Gavrielides MV, Gonzalez-Guerrico AM, Riobo NA and Kazanietz MG: Androgens regulate protein kinase Cdelta transcription and modulate its apoptotic function in prostate cancer cells. Cancer Res. 66:11792–11801. 2006. View Article : Google Scholar : PubMed/NCBI
24	Xing C, Ci X, Sun X, Fu X, Zhang Z, Dong EN, Hao ZZ and Dong JT: Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways. Neoplasia. 16:883–899. 2014. View Article : Google Scholar : PubMed/NCBI
25	Engedal N, Korkmaz CG and Saatcioglu F: C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Oncogene. 21:1017–1027. 2002. View Article : Google Scholar : PubMed/NCBI
26	Ikezoe T, Yang Y, Taguchi H and Koeffler HP: JNK interacting protein 1 (JIP-1) protects LNCaP prostate cancer cells from growth arrest and apoptosis mediated by 12–0-tetradecanoylphorbol-13-acetate (TPA). Br J Cancer. 90:2017–2024. 2004. View Article : Google Scholar : PubMed/NCBI